Literature DB >> 11391327

Long-term comparative trial of positive expiratory pressure versus oscillating positive expiratory pressure (flutter) physiotherapy in the treatment of cystic fibrosis.

P M McIlwaine1, L T Wong, D Peacock, A G Davidson.   

Abstract

OBJECTIVE: The objective was to evaluate the long-term effects of physiotherapy with an oscillating positive pressure device ("flutter") compared with physiotherapy with the use of a positive expiratory pressure (PEP) mask in patients with cystic fibrosis (CF). STUDY
DESIGN: Forty children with CF were randomly assigned to performing physiotherapy with the PEP mask or the flutter device for 1 year. Clinical status, pulmonary function, and compliance were measured at regular intervals throughout the study.
RESULTS: The flutter group demonstrated a greater mean annual rate of decline in forced vital capacity compared with the PEP group (-8.62 +/- 15.5 vs 0.06 +/- 7.9; P =.05) with a similar trend in forced expiratory volume in 1 second (-10.95 +/- 19.96 vs -1.24 +/- 9.9; P =.08). There was a significant decline in Huang scores (P =.05), increased hospitalizations (18 vs 5; P =.03), and antibiotic use in the flutter group.
CONCLUSION: Flutter was not as effective in maintaining pulmonary function in this group of patients with CF compared with PEP and was more costly because of the increased number of hospitalizations and antibiotic use.

Entities:  

Mesh:

Year:  2001        PMID: 11391327     DOI: 10.1067/mpd.2001.114017

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  21 in total

1.  Oscillating devices for airway clearance in people with cystic fibrosis.

Authors:  Lisa Morrison; Stephanie Milroy
Journal:  Cochrane Database Syst Rev       Date:  2020-04-30

Review 2.  Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis.

Authors:  Annemarie L Lee; Angela T Burge; Anne E Holland
Journal:  Cochrane Database Syst Rev       Date:  2017-09-27

3.  Lessons learned from a randomized trial of airway secretion clearance techniques in cystic fibrosis.

Authors:  Marci K Sontag; Alexandra L Quittner; Avani C Modi; Joni M Koenig; Don Giles; Christopher M Oermann; Michael W Konstan; Robert Castile; Frank J Accurso
Journal:  Pediatr Pulmonol       Date:  2010-03

Review 4.  Oscillating devices for airway clearance in people with cystic fibrosis.

Authors:  Lisa Morrison; Stephanie Innes
Journal:  Cochrane Database Syst Rev       Date:  2017-05-04

5.  Use of an oscillatory PEP device to enhance bronchial hygiene in a patient of post-H1NI pneumonia and acute respiratory distress syndrome with pneumothorax.

Authors:  Deepali Narula; Vivek Nangia
Journal:  BMJ Case Rep       Date:  2014-03-07

6.  Randomised crossover study of the Flutter device and the active cycle of breathing technique in non-cystic fibrosis bronchiectasis.

Authors:  Catherine S Thompson; S Harrison; J Ashley; K Day; D L Smith
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

7.  Airway clearance devices for cystic fibrosis: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2009-11-01

8.  Benefit of educational feedback for the use of positive expiratory pressure device.

Authors:  Gregory Reychler; Manon Jacquemart; William Poncin; Anne-Sophie Aubriot; Giuseppe Liistro
Journal:  Braz J Phys Ther       Date:  2015-09-01       Impact factor: 3.377

9.  The Efficacy of Flutter® and Active Cycle of Breathing Techniques in Patients with Bronchiectasis: A Prospective, Randomized, Comparative Study.

Authors:  Bilge Üzmezoğlu; Gündeniz Altıay; Levent Özdemir; Hakan Tuna; Necdet Süt
Journal:  Turk Thorac J       Date:  2018-06-12

10.  Current devices of respiratory physiotherapy.

Authors:  A Hristara-Papadopoulou; J Tsanakas; G Diomou; O Papadopoulou
Journal:  Hippokratia       Date:  2008       Impact factor: 0.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.